Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/31/2009 | US20090324702 Novel viral vector |
12/31/2009 | US20090324674 Genetically modified heart valve xenografts |
12/31/2009 | US20090324649 Leishmania vaccine using sand fly salivary immunogen |
12/31/2009 | US20090324640 Neuraminidase-deficient live influenza vaccines |
12/31/2009 | US20090324632 Methods and reagents for vaccination which generate a CD8 T cell immune response |
12/31/2009 | US20090324631 Polyvalent Vaccine |
12/31/2009 | US20090324630 Fusion multiviral chimeric antigen |
12/31/2009 | US20090324627 ISOLATED DNA DIRECTED 50kD REGULATORY SUBUNIT (POLD2) GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM CHOMOSOME 7 AND THEIR USES |
12/31/2009 | US20090324626 Isolated snare ykt6 genomic polynucleotide fragments from chomosome 7 and their uses |
12/31/2009 | US20090324608 Novel human protein kinase, phosphatase, and protease family members and uses thereof |
12/31/2009 | US20090324605 Interferon alpha antibodies and their uses |
12/31/2009 | US20090324603 Met fab and scfv fragments and methods of use |
12/31/2009 | US20090324601 Targeted binding agents directed to pdgfr-alpha and uses thereof |
12/31/2009 | US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
12/31/2009 | US20090324597 Unique long 16 (UL-16)-binding proteins (ULBP) specific immunoglobulin for use in diganosis cell proliferative disorders |
12/31/2009 | US20090324592 Compositions and methods for the diagnosis and treatment of tumor |
12/31/2009 | US20090324589 Methods for controlling blood pharmacokinetics of antibodies |
12/31/2009 | US20090324584 Nucleic Acid of Formula (I): GIXmGn, or (II): CIXmCn, in Particular as an Immune-Stimulating Agent/Adjuvant |
12/31/2009 | US20090324579 Anti-apoptotic protein antibodies |
12/31/2009 | US20090324576 Phage derived antimicrobial activities |
12/31/2009 | US20090324574 Esterases and Related Nucleic Acids and Methods |
12/31/2009 | US20090324566 T-Cell Receptor and Nucliec Acid Encoding the Receptor |
12/31/2009 | US20090324562 Defensin Proteins |
12/31/2009 | US20090324556 Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof |
12/31/2009 | US20090324553 Chimeric Viral Envelopes |
12/31/2009 | US20090324546 Method for modulating gene expression by modifying the cpg content |
12/31/2009 | US20090324512 Polypeptide constructs for nasal administration |
12/31/2009 | US20090324507 RNAi-Mediated Inhibition of Spleen Tyrosine Kinase-Related Inflammatory Conditions |
12/31/2009 | US20090324501 Vaccine Carrier |
12/31/2009 | US20090324490 Compositions and methods for the diagnosis and treatment of tumor |
12/31/2009 | US20090322327 Nanoparticle-amphipol complexes for nucleic acid intracellular delivery and imaging |
12/31/2009 | US20090321350 Method of growing bacteria for use in wastewater treatment |
12/31/2009 | US20090321264 Concentration and purification of analytes using electric fields |
12/31/2009 | US20090320831 Self processing plants and plant parts |
12/31/2009 | DE112008000275T5 Pflanzen mit verbesserten Ertragsmerkmalen und/oder erhöhter Resistenz gegen abiotischen Stress und Verfahren zu ihrer Herstellung Plants having enhanced yield-related traits and / or increased resistance to abiotic stress and process for their preparation |
12/30/2009 | WO2009158729A2 Compounds and methods for diagnosis and treatment of chagas disease |
12/30/2009 | WO2009158716A1 Improved protein production and storage in plants |
12/30/2009 | WO2009158694A1 Improved protein production and storage in plants |
12/30/2009 | WO2009158658A2 Induction of flocculation in photosynthetic organisms |
12/30/2009 | WO2009158614A1 Novel astrovirus |
12/30/2009 | WO2009158563A1 Method for treating or preventing radiation damage by in vivo gene therapy |
12/30/2009 | WO2009158470A2 Toxin genes and methods for their use |
12/30/2009 | WO2009158464A2 Thermoactive sivagm sab reverse transcriptase |
12/30/2009 | WO2009158364A1 Regulated genetic suicide mechanism compositions and methods |
12/30/2009 | WO2009158139A2 Engineering of xylose reductase and overexpression of xylitol dehydrogenase and xylulokinase improves xylose alcoholic fermentation in the thermotolerant yeast hansenula polymorpha |
12/30/2009 | WO2009158040A2 Cancer platinum resistance detection and sensitization method |
12/30/2009 | WO2009157771A2 Antibody producing non-human mammals |
12/30/2009 | WO2009157750A1 A method for identifying a pork content in a food |
12/30/2009 | WO2009157683A2 Rt-pcr method using n-primer and kit for rt-pcr comprising n-primer |
12/30/2009 | WO2009157679A1 Nucleic acid extraction apparatus |
12/30/2009 | WO2009157505A1 Telomerase inhibitor |
12/30/2009 | WO2009157465A1 Standard molecule for use in real-time pcr test, and detection of the standard molecule |
12/30/2009 | WO2009157452A1 Cyclic gmp detection method |
12/30/2009 | WO2009157376A1 Genetically modified plant capable of biosynthesizing capsinoid |
12/30/2009 | WO2009157251A1 Method of diagnosing integration dysfunction syndrome |
12/30/2009 | WO2009157219A1 Method of electrochemically detecting nucleic acid with the use of dna conjugate |
12/30/2009 | WO2009157204A1 Diagnosis/therapeutic strategy for gynecological cancer by utilizing micro-rna as biomarker |
12/30/2009 | WO2009157201A1 Method and kit for preparing ips cells |
12/30/2009 | WO2009157000A1 TOMATO SlMYB12 TRANSCRIPTION FACTOR AND GENETIC SELECTION THEREOF |
12/30/2009 | WO2009156853A2 Compounds, compositions, and methods useful for modulating the expression of histone deacetylase (hdac) gene expression and/or activity |
12/30/2009 | WO2009156730A1 Treatment of epithelial fragility disorders |
12/30/2009 | WO2009156688A2 New streptomyces beta-vulgaris strain, culture filtrate, derived active compounds and use thereof in the treatment of plants |
12/30/2009 | WO2009156687A2 New streptomyces barakatei strain, culture filtrate, derived active compounds and use thereof in the treatment of plants |
12/30/2009 | WO2009156545A1 Plastidial thioredoxins: overexpression and biotechnological applications |
12/30/2009 | WO2009156496A1 Plant improvement method |
12/30/2009 | WO2009156469A1 Recombinant cells and plants for synthesis of very long chains fatty acid (vlcfa) |
12/30/2009 | WO2009156405A1 Novel immunoadjuvant flagellin-based compounds and use thereof |
12/30/2009 | WO2009156371A1 Genes for modulating coffee maturation and methods for their use |
12/30/2009 | WO2009156360A1 Plants having enhanced yield-related traits and a method for making the same |
12/30/2009 | WO2009156214A1 Recombinant cell producing 2-hydroxyisobutyric acid |
12/30/2009 | WO2009156172A1 System for the determination of molecules altering the function of interferon, method therefor and compounds altering interferon activity |
12/30/2009 | WO2009156137A1 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
12/30/2009 | WO2009155961A1 Expression vectors based on modified ribosomal protein promoters and uses thereof in post-transcriptional assessment |
12/30/2009 | WO2009155842A1 Fusion protein of onconase and toxin transmembrane domain and preparation method and use thereof |
12/30/2009 | WO2009155726A2 Humanization of rabbit antibodies using a universal antibody framework |
12/30/2009 | WO2009155723A2 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα |
12/30/2009 | WO2009155662A1 A tumour suppressor protein, caspase-2 |
12/30/2009 | WO2009155633A1 Method of producing yeast biomass |
12/30/2009 | WO2009137145A9 Transcriptional control in alicyclobacillus acidocaldarius and associated genes, proteins, and methods |
12/30/2009 | WO2009136791A3 Novel phytases |
12/30/2009 | WO2009132351A3 Anti-sense microrna expression vectors |
12/30/2009 | WO2009132116A3 Transformation and engineered trait modification in miscanthus species |
12/30/2009 | WO2009129797A3 Stable lysis buffer mixture for extracting nucleic acids |
12/30/2009 | WO2009126462A3 Methods and compositions for improving plant health |
12/30/2009 | WO2009124295A3 Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity |
12/30/2009 | WO2009117553A3 Enhancing vessel lesion homing and repair potential of stem cells |
12/30/2009 | WO2009111755A3 Compensating for atrioventricular block using a nucleic acid encoding a sodium channel or gap junction protein |
12/30/2009 | WO2009090381A3 Glycosyl hydrolase polypeptides |
12/30/2009 | WO2009085468A3 A human non-antibody peptide or protein phage library |
12/30/2009 | WO2009085169A3 Diacylglycerol acyltransferase 2 genes and proteins encoded thereby from algae |
12/30/2009 | WO2009080743A3 Plants with increased yield (ko nue) |
12/30/2009 | WO2009079592A3 Modulating immune system development and function through microrna mir-146 |
12/30/2009 | WO2009078973A3 Microbial conversion of oils and fatty acids to high-value chemicals |
12/30/2009 | WO2009064920A3 Compounds and methods for modulating protein expression |
12/30/2009 | WO2009051823A3 Bacterial artificial chromosome containing feline herpes virus type 1 genome and uses thereof |
12/30/2009 | WO2009049284A3 Compositions and methods for improved glycoprotein sialylation |
12/30/2009 | WO2009045545A3 Antidotes for agonistic aptamers |
12/30/2009 | WO2009021191A3 Improved t7 expression system |
12/30/2009 | WO2008150473A3 Cytochrome p450 genes conferring herbicide resistance |
12/30/2009 | WO2008131215A3 Engineered phosphite dehydrogenase mutants |